Overallotment option exercise and net proceeds
Company: TeraWulf
The claim, verbatim
Underwriters exercised their option and purchased an additional 3,000,000 shares at $0.68 per share, resulting in total net proceeds of approximately $25.99 million after deducting underwriting discounts and commissions and estimated offering expenses.
Source (primary)
TeraWulf 8-K filed 2023-02-09 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “On February 8, 2023, the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 3,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $1.91 million, or approximately $25.99 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms TeraWulf 8-K filed 2023-02-09
Quote: “On February 8, 2023, the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 3,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $1.91 million, or approximately $25.99 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”